Eltoprazine attenuates L-DOPA induced dyskinesia along with GABA and Glutamate release in rat substantia nigra. Paolone, Giovanna; Arcuri, A; Brugnoli, A; Morari, M. details >>	Federation of European Neuroscience Societies, Federation of European Neuroscience Societies pp: 2000-2000, Anno: 2014

Nanoparticulate lipidic dispersions for bromocriptine delivery Esposito, Elisabetta; P., Mariani; Ravani, Laura; Contado, Catia; M., Drechsler; Morari, Michele; Cortesi, Rita	APGI - ADRITELF, Proceedings of 3rd Conference on “Innovation in Drug Delivery: Advances in Local Drug Delivery” pp: 95-95, Anno: 2013

Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesia in a rat model of Parkinson�s Disease Morari, Michele; Calo', Girolamo; Marti, Matteo	Society for Neuroscience, Soc Neurosci Abstract Vol. 892.15, No. 1, pp: 101-101, Anno: 2007

NR2A and NR2B Subunit Selective NMDA antagonists improve motor performance and reduce pallidal GABA release in 6-OHDA hemilesioned rats Fantin, Martina; Auberson, Yp; Morari, Michele	Society for Neuroscience, Soc Neurosci Abstract Vol. 893.3, No. 1, pp: 101-101, Anno: 2007

Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates Mela, Flora; Marti, Matteo; Cenci, Ma; Morari, Michele	Society for Neuroscience, Soc Neurosci Abstract Vol. 590.26, No. 1, pp: 34-34, Anno: 2007

L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia Mela, Flora; Dekundy, A; Marti, Matteo; Morari, Michele	G Di Chiara, E carboni, V Valentini, E Acquas,, Monitoring Molecules in Neuroscience pp: 530-532, Anno: 2006

Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa Marti, Matteo; Mela, Flora; Raimondi, M; Morari, Michele	Di Chiara G, Carboni E, Valentini V, Acquas E, Monitoring molecules in neuroscience pp: 77-79, Anno: 2006

Differential regulation of striato-nigral and striato-pallidal pathways by striatal NR2A and NR2B subunit containing receptors Fantin, Martina; Auberson, Y; Morari, Michele	Di Chiara G, Carboni E, Valentini V, Acquas E, Monitoring molecules in neuroscience pp: 345-347, Anno: 2006

Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models Marti, Matteo; Mela, Flora; Fantin, Martina; Guerrini, Remo; Morari, Michele details >>	European Neuropeptide Club, Proceedings of the XIV European Neuropeptides Club Meeting pp: 20-20, Anno: 2004

Solid lipid nanoparticles as delivery systems for parkinson’s therapy Esposito, Elisabetta; M., Fanti; Marti, Matteo; M., Drechsler; P., Mariani; Menegatti, Enea; Morari, Michele; Cortesi, Rita details >>	CRS Italy local chapter, “Multidisciplinar strategies to target the Central Nervous System” pp: 21-22, Anno: 2009

Nanostructured lipid carriers as delivery systems for parkinson’s therapy Esposito, Elisabetta; Fantin, Martina; Marti, Matteo; M., Drechsler; P., Mariani; Menegatti, Enea; Morari, Michele; Cortesi, Rita details >>	APV, Proceedings of 6th PBP World Meeting pp: ---, Anno: 2008

Nociceptin/orphanin FQ receptor antagonists reverse parkinsonism in MPTP-treated mice and non-human primates Morari, Michele; Viaro, Riccardo; Marti, Matteo; Sanchez Pernaute, R.; Isacson, O. details >>	MOVEMENT DISORDERS Vol. 22 (Suppl 16), No. 1, pp: S228-S228, Anno: 2007

Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors Marti, Matteo; Mela, Flora; Fantin, Martina; Viaro, Riccardo; Morari, Michele details >>	BEHAVIOURAL PHARMACOLOGY Vol. 17, No. 1, pp: 536-536, Anno: 2006

Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats Viaro, Riccardo; Marti, Matteo; Morari, Michele; Franchi, Gianfranco details >>	ACTA PHYSIOLOGICA Vol. 188 (Supp 652), No. 1, pp: 5-5, Anno: 2006